Search
for

    Did you mean Interleukin-17A?
    Glossary Interleukin-17A

    is a cytokine involved in inflammation and immune responses

    Interleukin-17A (IL-17A) is a type of cytokine, which is a protein that helps cells communicate in immune responses and stimulates the movement of cells towards sites of inflammation, infection, and trauma. IL-17A is particularly important in the body's defense against bacterial and fungal infections, but it is also implicated in autoimmune diseases like psoriasis and rheumatoid arthritis due to its role in promoting inflammation.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. <i>Trichophyton tonsurans</i>‐induced kerion celsi with decreased defensin expression and paradoxically increased interleukin‐17A production The Journal of Dermatology · 2019 · 7 citations
    2. Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata Kufa Medical journal · 2024
    3. Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata Dermatology Reports · 2021
    4. Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma Ukraïnsʹkij žurnal medicini, bìologìï ta sportu · 2021
    5. Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris Case Reports in Dermatology · 2019 · 20 citations
    6. Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris Advances in Dermatology and Allergology · 2024 · 2 citations
    7. Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis JAAD Case Reports · 2020 · 3 citations
    8. IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice Nature Communications · 2025
    9. Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study The Egyptian Journal of Hospital Medicine · 2023
    10. Interleukins gene polymorphism in alopecia areata patients: a systematic review 2025 · 1 citations
    11. Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity Diseases · 2025
    12. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity 2019 · 57 citations
    13. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa JAMA dermatology · 2018 · 19 citations
    14. Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata BBA clinical · 2016 · 12 citations
    15. Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata Biomolecules · 2023 · 1 citations
    16. Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome The Journal of Dermatology · 2014 · 1 citations
    17. 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance Journal of Investigative Dermatology · 2024
    18. 371 Hair follicles are critical modulators of skin barrier function Journal of Investigative Dermatology · 2024
    19. 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis Journal of Investigative Dermatology · 2023
    20. Emerging Therapies for Acne Vulgaris American Journal of Clinical Dermatology · 2018 · 22 citations
    21. Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis Dermatology and Therapy · 2021 · 78 citations
    22. Sycosis Barbae Treated With Bimekizumab Australasian Journal of Dermatology · 2025
    23. Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis Biomedical Research and Therapy · 2021 · 6 citations
    24. Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study Cureus · 2025
    25. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment Gut · 2013 · 278 citations
    26. Targeting lymphoid-derived IL-17 signaling to delay skin aging Nature Aging · 2023 · 59 citations
    27. Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity Advances in Dermatology and Allergology · 2020 · 14 citations
    28. Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata South Eastern European Journal of Public Health · 2024
    29. Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung Qucosa (Saxon State and University Library Dresden) · 2024
    30. A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment Orphanet Journal of Rare Diseases · 2025